2nd Circ. Asked To Reverse $153M Vitamin C Antitrust Award
By Jeff Sistrunk ( April 8, 2014, 4:46 PM EDT) -- North China Pharmaceuticals Group Corp. and HeBei Welcome Pharmaceuticals Co. on Tuesday urged the Second Circuit to reverse a $153 million award against them in a class action over vitamin C price-fixing claims, arguing that the trial court disregarded Chinese laws that compelled them to engage in the alleged antitrust violations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.